Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Third Harmonic Bio Inc.

    NASDAQ: THRD · Real-Time Price · USD
    5.42
    0.01 (0.18%)
    At close: Jun 17, 2025, 10:38 AM

    Third Harmonic Bio Statistics

    Share Statistics

    Third Harmonic Bio has 45.13M shares outstanding. The number of shares has increased by 10.15% in one year.

    Shares Outstanding

    n/a
    		 45.13M

    Shares Change (YoY)

    n/a
    		 10.15%

    Shares Change (QoQ)

    n/a
    		 0.1%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 22.29M

    Failed to Deliver (FTD) Shares

    n/a
    		 132

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 1.52M, so 3.38% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.52M

    Short % of Shares Out

    n/a
    		 3.38%

    Short % of Float

    n/a
    		 5.54%

    Short Ratio (days to cover)

    n/a
    		 5.41

    Valuation Ratios

    The PE ratio is 9.44 and the forward PE ratio is -5.6. Third Harmonic Bio's PEG ratio is -0.04.

    PE Ratio

    n/a
    		 9.44

    Forward PE

    n/a
    		 -5.6

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.51

    P/FCF Ratio

    n/a
    		 -12.44

    PEG Ratio

    n/a
    		 -0.04
    Financial Ratio History

    Enterprise Valuation

    Third Harmonic Bio has an Enterprise Value (EV) of 147.55M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -3.25

    EV / EBIT

    n/a
    		 -4.28

    EV / FCF

    n/a
    		 -4.28

    Financial Position

    The company has a current ratio of 40.87, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 40.87

    Quick Ratio

    n/a
    		 40.87

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.07

    Debt / FCF

    n/a
    		 -0.09

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 15.95% and Return on Invested Capital is 20.42%.

    Return on Equity

    n/a
    		 15.95%

    Return on Assets

    n/a
    		 15.43%

    Return on Invested Capital

    n/a
    		 20.42%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $1,466,741.94

    Employee Count

    n/a
    		 31

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -58.22% in the last 52 weeks. The beta is 2.15, so Third Harmonic Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.15

    52-Week Price Change

    n/a
    		 -58.22%

    50-Day Moving Average

    n/a
    		 5

    200-Day Moving Average

    n/a
    		 8.23

    Relative Strength Index (RSI)

    n/a
    		 76.57

    Average Volume (20 Days)

    n/a
    		 574,807

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 58.87M

    Net Income

    n/a
    		 45.47M

    EBITDA

    n/a
    		 -45.42M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 1.09
    Full Income Statement

    Balance Sheet

    The company has 285.06M in cash and 3.21M in debt, giving a net cash position of 281.86M.

    Cash & Cash Equivalents

    n/a
    		 285.06M

    Total Debt

    n/a
    		 3.21M

    Net Cash

    n/a
    		 281.86M

    Retained Earnings

    n/a
    		 -159.69M

    Total Assets

    n/a
    		 279.84M

    Working Capital

    n/a
    		 270.89M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -34.5M and capital expenditures -10K, giving a free cash flow of -34.51M.

    Operating Cash Flow

    n/a
    		 -34.5M

    Capital Expenditures

    n/a
    		 -10K

    Free Cash Flow

    n/a
    		 -34.51M

    FCF Per Share

    n/a
    		 -0.83
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    THRD pays an annual dividend of $0.56, which amounts to a dividend yield of 2.71%.

    Dividend Per Share

    n/a
    		 $0.56

    Dividend Yield

    n/a
    		 2.71%

    Dividend Growth (YoY)

    n/a
    		 140%

    Payout Ratio

    n/a
    		 -45.16%

    Earnings Yield

    n/a
    		 10.59%

    FCF Yield

    n/a
    		 -8.04%
    Dividend Details

    Analyst Forecast

    The average price target for THRD is $5, which is -7.6% lower than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 -7.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 12.94

    Graham Upside

    n/a
    		 139.19%

    Scores

    Altman Z-Score

    n/a
    		 19.09

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist